Results 131 to 140 of about 21,834 (203)

The neuropharmacology of baclofen [PDF]

, 1988
AI Shapovalov, B Ault, B Ault, B Ault, B Ault, B Ault, B Sutor, B Sutor, BH Gähwiler, BH Gähwiler, BW Connors, CF Terrence, CG Swahn, CN Scholfield, CR Cain, D Stevens, DR Curtis, DR Curtis, DR Curtis, DR Gehlert, DR Hill, E Cherubini, E Knutsson, E Mugnaini, E Roberts, E Schlicker, EW Karbon, FK Pierau, FK Pierau, GAR Johnston, GE Fagg, GGS Collins, GP Wilkin, GW Price, H Fukuda, H Keberle, H Möhler, H Ono, HJ Bein, HL Haas, HR Olpe, HR Olpe, HR Olpe, J Davies, J Davies, J Davies, J Swaynok, JJ Dreifuss, JL Henry, JL Henry, JL Henry, JR Bianchine, JR Howe, JW Phillis, K Dunlap, K Koketsu, K Krnjevic, KJ Fotherby, KS Saito, M Desarmenien, M Fillenz, M Inoue, M Inoue, M Kato, MA Simmonds, MR Klee, N Auden, N Ogata, NG Bowery, NG Bowery, NG Bowery, NG Bowery, NR Newberry, NR Newberry, NR Newberry, P Ashby, P Krogsgaard-Larsen, P Polc, PR Wilson, R Benecke, R Capek, RA Davidoff, RD Pinnock, RF Schmidt, RH Evans, RJ Brady, RR Young, RW Birkmayer, S Fox, SJ Enna, SJ Potashner, SJ Potashner, SR Barry, SR Zukin, TH Lanthorn, TJ Blaxter, U Heinemann, U Misgeld, V Ben-Ari, W Haefely, W Haefely, W Laskey, W Laskey, W Zieglgänsberger, WJ Wojcik   +104 more
core   +1 more source

A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine. [PDF]

Int J Mol Sci, 2021
Imbrici P, Conte E, Blunck R, Stregapede F, Liantonio A, Tosi M, D'Adamo MC, De Luca A, Brankovic V, Zanni G.   +9 more
europepmc   +1 more source

Interneuron-Driven Ictogenesis in the 4-Aminopyridine Model: Depolarization Block and Potassium Accumulation Initiate Seizure-like Activity. [PDF]

Int J Mol Sci
Proskurina EY, Ergina JL, Zaitsev AV.
europepmc   +1 more source

Effects on low threshold mechanoreceptors in whisker hair follicles by 5-HT, Cd²⁺, tetraethylammonium, 4-aminopyridine, and Ba². [PDF]

Mol Pain, 2022
Sonekatsu M, Yamada H, Nishio N, Gu JG.
europepmc   +1 more source

Novel In-Frame FGF14 Deletion Causes Spinocerebellar Ataxia Type 27A: Clinical Response to Deep Brain Stimulation and 4-Aminopyridine. [PDF]

Mov Disord
Keller Sarmiento IJ, Bovenzi R, Kinsinger M, Kinsley L, Bustos BI, Krainc D, Mencacci NE.   +6 more
europepmc   +1 more source

(4-Aminopyridine)-PLGA-PEG as a Novel Thermosensitive and Locally Injectable Treatment for Acute Peripheral Nerve Injury. [PDF]

ACS Appl Bio Mater, 2021
Manto KM, Govindappa PK, Parisi D, Karuman Z, Martinazzi B, Hegarty JP, Talukder MAH, Elfar JC.   +7 more
europepmc   +1 more source

Investigation of the Effects of Blocking Potassium Channels With 4-Aminopyridine on Paclitaxel Activity in Breast Cancer Cell Lines. [PDF]

Cancer Rep (Hoboken)
Cüce-Aydoğmuş EM, İnhan-Garip GA.
europepmc   +1 more source

4-Aminopyridine: A Single-Dose Diagnostic Agent to Differentiate Axonal Continuity in Nerve Injuries. [PDF]

Mil Med, 2021
Gurjar AA, Manto KM, Estrada JA, Kaufman M, Sun D, Talukder MAH, Elfar JC.   +6 more
europepmc   +1 more source

4-Aminopyridine in pediatric traumatic spinal cord injury: A case report. [PDF]

J Spinal Cord Med
Hillaker E, Chen J, Dean J, Yeh N, Sadowsky C, Elfar J.   +5 more
europepmc   +1 more source

Overcoming presynaptic effects of VAMP2 mutations with 4-aminopyridine treatment. [PDF]

Hum Mutat, 2020
Simmons RL, Li H, Alten B, Santos MS, Jiang R, Paul B, Lalani SJ, Cortesi A, Parks K, Khandelwal N, Smith-Packard B, Phoong MA, Chez M, Fisher H, Scheuerle AE, Shinawi M, Hussain SA, Kavalali ET, Sherr EH, Voglmaier SM.   +19 more
europepmc   +1 more source